Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`SubstItute for form 1449/PTO
`_
`
`Complete if Known
`
`—15603013
`_D t
`—g,5AlEl3\7A21l01\/:/'ll'am;
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT —1636
`(Use as many sheets as necessary)
`Nen P. Hammen
`Attorney DocketNumber
`I 4854-701.402
`
`|
`
`|
`
`.—
`
` L3
`
`
`
`Examiner
`lnitials*
`
`.
`
`D
`
`ocumen
`
`t N
`
`b
`um er
`
`Publication Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Pages, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`U. S. PATENT DOCUMENTS
`
`
`
`Number-Kind Codez (”km")
`
`US-5854033
`
`US-6287824
`
`US-6728129
`
`US-8500979
`
`US-20040219663
`
`US-20050112679
`
`US-20060160138
`
`US-20120164633
`
`LIZARDI; Paul M.
`
`LIZARDI; Paul M.
`
`LINDSEY; Jonathan S. et al.
`
`ELIBOL; Oguz H. et al.
`
`PAGE; Robert D. etal.
`
`MYERSON;Joe|etal.
`
`CHURCH; George
`
`LAFFLER; Thomas
`
`US-20130164308
`
`06 27 2013
`
`FOLETT'? DaVide LUCiano
`[US] et al.
`
`US-20150293102
`
`10 15 2015
`
`SHIM; Jung-Uk
`
`US-20160289758
`
`10-06 2016
`
`AKESON; Mark A. et al.
`
`US-20170066844
`
`03-09 2017
`
`GLANVILLE; Jacob
`
`US-20170175110
`
`06 22 2017
`
`JACOBSON? Joseph [US] et
`
`US-20170253644
`
`09-07 2017
`
`STEYAERT; Jan et al.
`
`US-20180326388
`
`11-15 2018
`
`BANYAI; William [Us] et al.
`
`US-20190060345
`
`02-28-2019
`
`:IARR'SON? Nancy [ca] et
`
`Examiner
`Signature
`
`Date
`Considered
`
`1
`2
`*EXAMINER: lnitial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`4
`considered.
`lnclude copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional). See Kinds Codes of USPTO Patent
`5
`Documents at wwwus ate.r UV or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. Kind of document by the appropriate symbols as indicated on the
`document under WlPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language Translation is attached. This collection of information is required by
`37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application
`form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this
`burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`SubstItute for form 1449/PTO
`_
`
`Complete if Known
`
`—15603013
`_D t
`—g,5AlEl:IA2II)1\/Il'll'am;
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT —1636
`(Use as many sheets as necessary)
`Nen P. Hammen
`Attorney DocketNumber
`I 4854-701.402
`
`|
`
`|
`
`.—
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner
`lnitials*
`
`.
`
`Foreign Patent Document
`
`Publication
`Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Pages, Columns, Lines,
`Where Relevant Passages
`Or Relevant Figures Appear
`
`11-03-2016
`
`
`
`Country Codea’Number’I’Kind Code5 (if known)
`
`WO-2006023144
`
`03-02-2006 BIOREN INC.
`
`WO-2008045380
`
`04-17-2008
`
`CODON DEVICES,
`INC.
`
`WO-2016161244-A2
`
`WO-2016173719-A1
`
`SCRIPPS
`10-06-2016 RESEARCH INST
`
`[US]
`
`ABCHECK S R O
`
`
`
`Examiner
`Signature
`
`
`
`Date
`Considered
`
`1
`2
`*EXAMINER: lnitial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`4
`considered.
`lnclude copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional). See Kinds Codes of USPTO Patent
`Documents at Yv‘W'v‘LE
`5
`s ate.r CV or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. Kind of document by the appropriate symbols as indicated on the
`document under WlPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language Translation is attached. This collection of information is required by
`37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application
`form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this
`burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Substitute for form 1449/PTO
`_
`
`Complete if Known
`
`—15603013
`_D t
`—§EA§$§P1V7V-u-am;
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT —1636
`(Use as many sheets as necessary)
`Nen P. Hammen
`Attorney DocketNumber
`A 4854-701.402
`
`|
`
`|
`
`
`
`
`
`.—
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`.
`
`Include name ofthe author(in CAPITAL LETTERS),titIe of the article(when appropriate), title of
`the item (book,magazine,journal,serial,symposium,cata|og,etc.),date,page(s),vo|ume-issue
`number(s),publisher, city and/or country where published.
`
`N
`
`_I
`
`Eroshenko et al.: Gene Assembly from Chip-Synthesized Oligonucleotides; Current Protocols in
`Chemical biology 4: 1-17 (2012)
`
`European Patent Application No. 148346653 Further Examination Report dated November 28,
`2018.
`
`European Patent Application No. 16847497.1 Extended European Search Report dated
`January 9,2019.
`
`International Application No. PCT/U82017/026232 International Preliminary Report on
`Patentability dated February 26, 2019.
`
`International Application No. PCT/U82017/045105 International Preliminary Report on
`Patentability dated February 5, 2019.
`
`International Application No. PCT/U82018/050511 International Search Report and Written
`Opinion dated January 11, 2019.
`
`International Application No. PCT/U82019/012218 International Search Report and Written
`Opinion dated March 21,2019.
`
`Douthwaite et al.: Affinity maturation of a novel antagonistic human monoclonal antibody with a
`long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1; mAbs, vol. 7, Iss. 1, pp.
`152-166 (01Jan2015).
`
`JO et al.: Engineering therapeutic antibodies targeting G-protein-coupled receptors;
`Experimental & Molecular Medicine; 48; 9 pages (2016).
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. 1 Applicant’s unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached. This collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering,
`preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Substitute for form 1449/PTO
`_
`
`Complete if Known
`
`—15603013
`_D t
`—§EA§$§P1V7V-u-am;
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT —1636
`(Use as many sheets as necessary)
`Nen P. Hammen
`Attorney DocketNumber
`A 4854-701.402
`
`|
`
`|
`
` N
`
`
`
`.—
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`.
`
`Include name ofthe author(in CAPITAL LETTERS),titIe of the article(when appropriate), title of
`the item (book,magazine,journal,serial,symposium,cata|og,etc.),date,page(s),vo|ume-issue
`number(s),publisher, city and/or country where published.
`
`Martinez-Torrecuadrada et al.: Targeting the Extracellular Domain of Fibroblast Growth Factor
`Receptor 3 with Human Single-Chain Fv Antibodies Inhibits Bladder Carcinoma Cell Line
`Proliferation; Clinical Cancer Research; vol. 11; pp. 6282-6290 (2005).
`
`US. Patent Application No. 15/187,714 Office Action dated April 4, 2019.
`
`US. Patent Application No. 15/015,059 Office Action dated February 7, 2019.
`
`US. Patent Application No. 15/156,134 Office Action dated April 4, 2019.
`
`US. Patent Application No. 15/268,422 Final Office Action dated March 1, 2019.
`
`US. Patent Application No. 15/377,547 Final Office Action dated February 8, 2019.
`
`US. Patent Application No. 15/433,909 Non-Final Office Action dated February 8, 2019.
`
`US. Patent Application No. 15/151,316 Final Office Action dated February 21,2019.
`
`WU, et al. "Sequence-Specific Capture of Protein-DNA Complexes for Mass Spectrometric
`Protein Identification" PLoS ONE. 20 October 2011, Vol. 6, No. 10.
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. 1 Applicant’s unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached. This collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering,
`preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`